Table 3 Surgical stage
Uterine cancer | ELC | US | Total |
|---|---|---|---|
Endometrial cancer | |||
  Ia (no myometrial invasion) | 4 (18.8) | 3 (4.4) | 7 (7.8) |
 Ib (myometrial invasion up to 50%) | 5 (22.1) | 33 (49.2) | 38 (42.6) |
  Ic (myometrial invasion >50%) | 10 (45.4) | 25 (37.3) | 35 (39.3) |
  IIIa | 1 (4.5) | 1 (1.4) | 2 (2.2) |
  IIIc | 2 (9.0) | 5 (7.4) | 7 (7.8) |
  Lymph node positive | 2 (9) | 5 (7.4) | 7 (7.8) |
  Pelvic lymph node positive | 2 (9) | 5 (7.4) | 7 (7.8) |
  Infra-aortic lymph positive | 0 (0) | 0 (0) | 0 (0) |
Cervical cancer | |||
  I A 1 | 2 (28.5) | 3 (13.0) | 5 (16.6) |
  I A 2 | 5 (71.5) | 10 (43.4) | 15 (50.0) |
  I B 1 | 0 (0) | 4 (17.3) | 4 (13.3) |
  Locally advanced cancer | 0 (0) | 6 (26.0) | 6 (20.0) |
  Lymph node positive | 0 (0) | 2 (8.6) | 2 (6.6) |